CERN-MEDICIS: A Unique Facility for the Production of Non-Conventional Radionuclides for the Medical Research

Duchemin, Charlotte; Ramos, J.P.; Stora, T.; Aubert, Elodie; Audouin, Nadia; Barbero, E.; Barozier, Vincent; Bernardes, A. P.; Bertreix, Philippe; Boscher, A; Burnel, D.; Catherall, R.; Cirilli, M.; Chevalley, E.; Cocolios, T. E.; Comte, Jérôme; Crepieux, B.; Deschamps, Marcelo; Dockx, Kristof; Dorsival, A.; Fedosseev, Valentin; Fernier, P.; Formento-Cavaier, R.; Gadelshin, Vadim; Gilardoni, S.; Grenard, Jean-Louis; Haddad, Férid; Heinke, Reinhard; Juif, B.; Khan, M.; Köster, U.; Lambert, Laura; Lilli, G.; Lunghi, Giacomo; Marsh, B. A.; Palenzuela, Y. Martinez; Martins, Ricardo; Marzari, S.; Menaa, N.; Michel, Nathalie; Pozzi, Fabio; Riccardi, F; Riegert, J.; Riggaz, Nicolas; Rothe, S.; Stegemann, S.; Talip, Zeynep; Thiboud, J.; Meulen, Nicholas P. van der; Vollaire, J.; Vuong, Nhat-Tan; Wendt, K.; Wilkins, Shane

doi:10.18429/jacow-ipac2020-thvir13

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Meanwhile, other Tb radionuclides, such as 149 Tb, 152 Tb, and 155 Tb, are mostly produced by spallation reactions on natural tantalum targets through the reaction nat Ta(p,x) 149,152,155 Tb. This production route has several limitations: on one hand, there are few high-energy accelerator facilities; on the other hand, this route needs an expensive online mass separation procedure to isolate the desired radionuclide with, today, a low efficiency (Duchemin et al, 2020). Heavy-ion-induced reactions have also been considered to produce 149 Tb and 152 Tb (Lahiri et al, 1999;Nayak et al, 1999;Allen et al, 2001;Maiti, 2011).…”

Section: Introductionmentioning

confidence: 99%

Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb

Wang,

Sounalet,

Guertin

et al. 2023

Applied Radiation and Isotopes

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb

Wang,

Sounalet,

Guertin

et al. 2023

Applied Radiation and Isotopes

View full text Add to dashboard Cite

Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung

Neels¹,

Kratochwil²,

Patt³

2021

Der Nuklearmediziner

View full text Add to dashboard Cite

Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations

et al. 2021

Self Cite

View full text Add to dashboard Cite

This work presents the production cross-sections of Ce, Tb and Dy radionuclides produced by 300 MeV to 1.7 GeV proton-induced spallation reactions in thin tantalum targets as well as the related Thick Target production Yield (TTY) values and ratios. The motivation is to optimise the production of terbium radionuclides for medical applications and to find out at which energy the purity of the collection by mass separation would be highest. For that purpose, activation experiments were performed using the COSY synchrotron at FZ Jülich utilising the stacked-foils technique and γ spectrometry with high-purity germanium detectors. The Al-27(p,x)Na-24 reaction has been used as monitor reaction. All experimental data have been systematically compared with the existing literature.

show abstract

CERN-MEDICIS: A Unique Facility for the Production of Non-Conventional Radionuclides for the Medical Research

Cited by 3 publications

References 0 publications

Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb

Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb

Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung

Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations

Contact Info

Product

Resources

About